INFLUENCE OF CYTOTOXIC T LYMPHOCYTE-ASSOCIATED ANTIGEN 4 (CTLA4) COMMON POLYMORPHISMS ON OUTCOME IN TREATMENT OF MELANOMA PATIENTS WITH CTLA-4 BLOCKADE

Blockade of the Cytotoxic T Lymphocyte-associated Antigen 4 (CTLA-4), a down-regulator of T cell activation, can cause cancer regression in patients with metastatic melanoma. However, not all patients respond well to the therapy and some develop severe autoimmune reactions. We hypothesized that comm...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Breunis, Willemijn B, Tarazona-Santos, Eduardo, Chen, Renee, Kiley, Maureen, Rosenberg, Steven A, Chanock, Stephen J
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3276400/
https://ncbi.nlm.nih.gov/pubmed/18528295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CJI.0b013e31817fd8f3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items